The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The role of dietary fatty acids in the pathology of metabolic syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Mensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811
Hayhurst, G. P., Lee, Y.-H., Lambert, G., Ward, J. M., & Gonzalez, F. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1393-1403.2001 · Cited by 1,107
The Effect of Mediterranean Diet on Metabolic Syndrome and its Components
Kastorini, C.-M., Milionis, H. J., Esposito, K., Giugliano, D., Goudevenos, J. A., & Panagiotakos, D. B. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.073 · Cited by 1,087 · cited 1×
“obesity, type 2 diabetes, cardiovascular events [49] and metabolic syndrome [50,51].”
Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels
Bonanome, A., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181905 · Cited by 915
Research works printed but not linked: 147
- Ford, 2005, Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence, Diabetes Care, 28, 1769, 10.2337/diacare.28.7.1769 · DOI · Paper page
- Rioux, 2007, Saturated fatty acids: simple molecular structures with complex cellular functions, Curr Opin Clin Nutr Metab Care, 10, 752
- Kris-Etherton, 1997, Individual fatty acid effects on plasma lipids and lipoproteins: human studies, Am J Clin Nutr, 65, 1628S, 10.1093/ajcn/65.5.1628S · DOI · Paper page
- Chappell, 1993, Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro, J Biol Chem, 268, 25487, 10.1016/S0021-9258(19)74418-4 · DOI
- Daumerie, 1992, Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools, Proc Natl Acad Sci U S A, 89, 10797, 10.1073/pnas.89.22.10797 · DOI
- Nicolosi, 1990, Effect of dietary fat saturation and cholesterol on LDL composition and metabolism, Arteriosclerosis, 10, 119, 10.1161/01.ATV.10.1.119 · DOI
- Lee, 2004, Dietary fatty acids regulate acyl-CoA: cholesterol acyltransferase and cytosolic cholesteryl ester hydrolase in hamsters, J Nutr, 134, 3239, 10.1093/jn/134.12.3239 · DOI
- Jackson, 2006, Saturated fat-induced changes in Sf 60-400 particle composition reduces uptake of LDL by HepG2 cells, J Lipid Res, 47, 393, 10.1194/jlr.M500382-JLR200 · DOI
- Spritz, 1969, Effects of dietary fats on plasma lipids and lipoproteins: an hypothesis for the lipid-lowering effect of unsaturated fatty acids, J Clin Invest, 48, 78, 10.1172/JCI105976 · DOI · Paper page
- Kris-Etherton, 2005, Dietary stearic acid and risk of cardiovascular disease: intake, sources, digestion, and absorption, Lipids, 40, 1193, 10.1007/s11745-005-1485-y · DOI
- Guillou, 2010, The key roles of elongases in mammalian fatty acid metabolism: insights from transgenic mice, Prog Lipid Res, 49, 186, 10.1016/j.plipres.2009.12.002 · DOI · Paper page
- Rioux, 2000, Myristic acid, unlike palmitic acid, is rapidly metabolized in cultured rat hepatocytes, J Nutr Biochem, 11, 198, 10.1016/S0955-2863(00)00065-6 · doi:10.1016/s0955-2863(00)00065-6
- Nestel, 2008, Effects of dairy fats within different foods on plasma lipids, J Am Coll Nutr, 27, 735S, 10.1080/07315724.2008.10719751 · DOI
- Rioux, 2011, Regulation of mammalian desaturases by myristic acid: N-terminal myristoylation and other modulations, Biochim Biophys Acta, 1811, 1, 10.1016/j.bbalip.2010.09.005 · DOI
- de Wildt, 1984, Influence of dietary rapeseed oil and erucic acid upon myocardial performance and hemodynamics in rats, Toxicol Appl Pharmacol, 74, 99, 10.1016/0041-008X(84)90275-8 · doi:10.1016/0041-008x(84)90275-8
- Tripodi, 1991, Effect of fish oil and coconut oil diet on the LDL receptor activity of rat liver plasma membranes, Biochim Biophys Acta, 1083, 298, 10.1016/0005-2760(91)90086-W · DOI
- Fernandez, 1989, Dietary fat-mediated changes in hepatic apoprotein B/E receptor in the guinea pig: effect of polyunsaturated, monounsaturated, and saturated fat, Metabolism, 38, 1094, 10.1016/0026-0495(89)90046-2 · DOI
- Yu-Poth, 2005, Long-chain polyunsaturated fatty acids upregulate LDL receptor protein expression in fibroblasts and HepG2 cells, J Nutr, 135, 2541, 10.1093/jn/135.11.2541 · DOI
- Shepherd, 1980, Sequential changes in plasma lipoproteins and body fat composition during polyunsaturated fat feeding in man, Br J Nutr, 44, 265, 10.1079/BJN19800040 · doi:10.1079/bjn19800040
- Johnson, 1985, St Clair RW, Rudel LL. Effects of the degree of saturation of dietary fat on the hepatic production of lipoproteins in the African green monkey, J Lipid Res, 26, 403, 10.1016/S0022-2275(20)34354-6 · DOI
- Lottenberg, 1996, Plasma cholesteryl ester synthesis, cholesteryl ester transfer protein concentration and activity in hypercholesterolemic women: effects of the degree of saturation of dietary fatty acids in the fasting and postprandial states, Atherosclerosis, 126, 265, 10.1016/0021-9150(96)05914-X · DOI
- Uehara, 2007, Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element, Atherosclerosis, 191, 11, 10.1016/j.atherosclerosis.2006.04.018 · DOI
- Lichtenstein, 1994, Hypercholesterolemic effect of dietary cholesterol in diets enriched in polyunsaturated and saturated fat, Arterioscler Thromb, 14, 168, 10.1161/01.ATV.14.1.168 · DOI
- Louheranta, 1996, Linoleic acid intake and susceptibility of very-low-density and low-density lipoproteins to oxidation in men, Am J Clin Nutr, 63, 698, 10.1093/ajcn/63.5.698 · DOI
- Rajamoorthi, 2005, Packing and viscoelasticity of polyunsaturated omega-3 and omega-6 lipid bilayers as seen by (2)H NMR and X-ray diffraction, J Am Chem Soc, 127, 1576, 10.1021/ja046453b · DOI
- Rustan, 1988, Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acylcoenzyme A: 1,2-diacylglycerolacyltransferase, J Lipid Res, 29, 1417, 10.1016/S0022-2275(20)38418-2 · DOI · Paper page
- Lottenberg, 1992, Effect of dietary fish oil on the rate of very low density lipoprotein triacylglycerol formation and on the metabolism of chylomicrons, Lipids, 27, 326, 10.1007/BF02536145 · DOI
- Davidson, 2006, Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids, Am J Cardiol, 98, 27, 10.1016/j.amjcard.2005.12.024 · DOI · Paper page
- Sampath, 2005, Polyunsaturated fatty acid regulation of genes of lipid metabolism, Annu Rev Nutr, 25, 317, 10.1146/annurev.nutr.25.051804.101917 · DOI · Paper page
- Rodriguez-Cruz, 2005, Molecular mechanisms of action and health benefits of polyunsaturated fatty acids, Rev Invest Clin, 57, 457
- de Lorgeril, 1999, Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study, Circulation, 99, 779, 10.1161/01.CIR.99.6.779 · DOI · Paper page
- Balk, 2006, Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review, Atherosclerosis, 189, 19, 10.1016/j.atherosclerosis.2006.02.012 · DOI · Paper page
- Reaven, 1994, Effect of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans, Arterioscler Thromb, 14, 557, 10.1161/01.ATV.14.4.557 · DOI · Paper page
- Grundy, 1991, Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease, Arterioscler Thromb, 11, 1619, 10.1161/01.ATV.11.6.1619 · DOI
- Jones, 1994, Effect of dietary fat selection on plasma cholesterol synthesis in older, moderately hypercholesterolemic humans, Arterioscl Thromb, 14, 542, 10.1161/01.ATV.14.4.542 · doi:10.1161/01.atv.14.4.542
- Pérez-Martínez, 2011, Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus, Curr Pharm Des, 17, 769, 10.2174/138161211795428948 · DOI · Paper page
- Gillingham, 2011, Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors, Lipids, 46, 209, 10.1007/s11745-010-3524-y · DOI · Paper page
- Esposito, 2008, Mediterranean dietary patterns and chronic diseases, Am J Clin Nutr, 88, 1179, 10.1093/ajcn/88.4.1179 · DOI
- Sommerfeld, 1983, Trans unsaturated fatty acids in natural products and processed foods, Prog Lipid Res, 22, 221, 10.1016/0163-7827(83)90010-3 · DOI
- Matthan, 2004, Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women, Arterioscler Thromb Vasc Biol, 24, 1092, 10.1161/01.ATV.0000128410.23161.be · DOI
- Buonacorso, 2007, Macrophage cholesterol efflux elicited by human total plasma and by HDL subfractions is not affected by different types of dietary fatty acids, Am J Clin Nutr, 86, 1270, 10.1093/ajcn/86.5.1270 · DOI
- Matthan, 2001, Hydrogenated fat consumption affects acylation-stimulating protein levels and cholesterol esterification rates in moderately hypercholesterolemic women, J Lipid Res, 42, 1841, 10.1016/S0022-2275(20)31510-8 · DOI
- Zapolska-Downar, 2005, Trans fatty acids induce apoptosis in human endothelial cells, J Physiol Pharmacol, 56, 611
- Eckel, 2007, Understanding the complexity of trans fatty acid reduction in the American diet: American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group, Circulation, 115, 2231, 10.1161/CIRCULATIONAHA.106.181947 · DOI · Paper page
- Berry, 2009, Triacylglycerol structure and interesterification of palmitic and stearic acid-rich fats: an overview and implications for cardiovascular disease, Nutr Res Rev, 22, 3, 10.1017/S0954422409369267 · DOI · Paper page
- Hayes, 2001, Synthetic and modified glycerides: effects on plasma lipids, Curr Opin Lipidol, 12, 55, 10.1097/00041433-200102000-00010 · DOI
- Wang, 1982, Studies of the substrate specificity of purified human milk lipoprotein lipase, Lipids, 17, 278, 10.1007/BF02534942 · doi:10.1007/bf02534942
- Sundram, 2007, Stearic acid-rich interesterified fat and trans-rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humans, Nutr Metab, 4, 3, 10.1186/1743-7075-4-3 · DOI
- Nestel, 1995, Effect on plasma lipids of interesterifying a mix edible oils, Am J Clin Nutr, 62, 950, 10.1093/ajcn/62.5.950 · DOI
- Meijer, 1997, Interesterification of fats in margarine: effect on blood lipids, blood enzymes, and hemostasis parameters, Eur J Clin Nutr, 51, 527, 10.1038/sj.ejcn.1600437 · DOI
- Robinson, 2009, Influence of interesterification of a stearic acid-rich spreadable fat on acute metabolic risk factors, Lipids, 44, 17, 10.1007/s11745-008-3253-7 · DOI
- Serfaty, 2008, Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis, Diabetes Metab, 34, 634, 10.1016/S1262-3636(08)74597-X · DOI
- Targher, 2008, Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients, Diabetologia, 51, 444, 10.1007/s00125-007-0897-4 · DOI · Paper page
- Daly, 2011, Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease, Expert Rev Gastroenterol Hepatol, 5, 253, 10.1586/egh.11.18 · DOI
- Westerbacka, 2005, Dietary fat content modifies liver fat in overweight nondiabetic subjects, J Clin Endocrinol Metab, 90, 2804, 10.1210/jc.2004-1983 · DOI · Paper page
- Machado, 2010, Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content, J Nutr, 140, 1127, 10.3945/jn.109.117937 · DOI
- Meijer, 2010, Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model, Metabolism, 59, 1092, 10.1016/j.metabol.2009.11.006 · DOI
- Targher, 2007, Non-alcoholic fatty liver disease and increased risk of cardiovascular disease, Atherosclerosis, 191, 235, 10.1016/j.atherosclerosis.2006.08.021 · DOI · Paper page
- Buse, 2007, American Heart Association; American Diabetes Association. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association, Circulation, 115, 114, 10.1161/CIRCULATIONAHA.106.179294 · DOI · Paper page
- Kolak, 2007, Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity, Diabetes, 56, 1960, 10.2337/db07-0111 · DOI · Paper page
- Westerbacka, 2007, Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects, Diabetes, 56, 2759, 10.2337/db07-0156 · DOI · Paper page
- Casaschi, 2005, Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters, Metabolism, 54, 403, 10.1016/j.metabol.2004.09.016 · DOI
- Wang, 2006, Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis, Endocrinology, 147, 943, 10.1210/en.2005-0570 · DOI · Paper page
- Malhi, 2006, Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis, J Biol Chem, 281, 12093, 10.1074/jbc.M510660200 · DOI · Paper page
- Lin, 2005, Hyperlipidemic effects of dietary saturated fats mediated through PGC-1 coactivation of SREBP, Cell, 120, 261, 10.1016/j.cell.2004.11.043 · DOI · Paper page
- Sampath, 2007, Stearoyl-CoA desaturase-1 mediates the prolipogenic effects of dietary saturated fat, J Biol Chem, 282, 2483, 10.1074/jbc.M610158200 · DOI · Paper page
- Oosterveer, 2009, High fat feeding induces hepatic fatty acid elongation in mice, PLoS One, 4, e6066, 10.1371/journal.pone.0006066 · DOI
- Inoue, 2005, Increased expression of PPARγ in high fat diet-induced liver steatosis in mice, Biochem Biophys Res Commun, 336, 215, 10.1016/j.bbrc.2005.08.070 · DOI · Paper page
- Ren, 1997, Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor, J Biol Chem, 272, 26827, 10.1074/jbc.272.43.26827 · DOI · Paper page
- Jump, 2011, Fatty acid regulation of hepatic lipid metabolism, Curr Opin Clin Nutr Metab Care, 14, 115
- Yoshikawa, 2002, Polyunsaturated fatty acids suppress sterol regulatory element binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements, J Biol Chem, 277, 1705, 10.1074/jbc.M105711200 · DOI · Paper page
- Pawar, 2002, Fatty acid regulation of liver X receptors (LXR) and peroxisome proliferator-activated receptor alpha (PPARalpha) in HEK293 cells, J Biol Chem, 277, 39243, 10.1074/jbc.M206170200 · DOI
- Howell, 2009, N-3 polyunsaturated fatty acids suppress insulin-induced SREBP-1c transcription via reduced transactivating capacity if LXR, Biochim Biophys Acta, 1791, 1190, 10.1016/j.bbalip.2009.08.008 · DOI
- Levin, 2005, Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists, Arterioscler Thromb Vasc Biol, 25, 135, 10.1161/01.ATV.0000150044.84012.68 · DOI · Paper page
- Cha, 2007, The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR, J Biol Chem, 282, 743, 10.1074/jbc.M605023200 · DOI · Paper page
- Duplus, 2002, Is there a single mechanism for fatty acid regulation of gene transcription?, Biochem Pharmacol, 64, 893, 10.1016/S0006-2952(02)01157-7 · DOI · Paper page
- Zhao, 2004, Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets, DNA Cell Biol, 23, 519, 10.1089/1044549041562267 · DOI
- Duran-Sandoval, 2005, The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition, J Biol Chem, 280, 29971, 10.1074/jbc.M501931200 · DOI · Paper page
- Pineda Torra, 2003, Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor, Mol Endocrinol, 17, 259, 10.1210/me.2002-0120 · DOI · Paper page
- Sinal, 2000, Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis, Cell, 102, 731, 10.1016/S0092-8674(00)00062-3 · DOI · Paper page
- Landschulz, 1994, Transcriptional control of the stearoyl-CoA desaturase-1 gene by polyunsaturated fatty acids, Biochem Biophys Res Comm, 200, 763, 10.1006/bbrc.1994.1516 · DOI
- Kohan, 2011, Chylomicron remnants and nonesterified fatty acids differ in their ability to inhibit genes involved in lipogenesis in rats, J Nutr, 141, 171, 10.3945/jn.110.129106 · DOI
- Uyeda, 2006, Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis, Cell Metab, 4, 107, 10.1016/j.cmet.2006.06.008 · DOI · Paper page
- Postic, 2007, ChREBP, a transcriptional regulator of glucose and lipid metabolism, Annu Rev Nutr, 27, 179, 10.1146/annurev.nutr.27.061406.093618 · DOI · Paper page
- Denechaud, 2007, Role of ChREBP in hepatic steatosis and insulin resistance, FEBS Lett, 582, 68, 10.1016/j.febslet.2007.07.084 · DOI · Paper page
- Uyeda, 2002, Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage, Biochem Pharmacol, 63, 2075, 10.1016/S0006-2952(02)01012-2 · DOI · Paper page
- Stabile, 1996, Posttranscriptional regulation of glucose-6-phosphate dehydrogenase by dietary polyunsaturated fat, Arch Biochem Biophys, 332, 269, 10.1006/abbi.1996.0342 · DOI
- Talukdar, 2005, Arachidonic acid inhibits the insulin induction of glucose-6-phosphate dehydrogenase via p38 MAP Kinase, J Biol Chem, 280, 40660, 10.1074/jbc.M505531200 · DOI
- Hertz, 1998, Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha, Nature, 392, 512, 10.1038/33185 · DOI · Paper page
- Rajas, 2002, Polyunsaturated fatty acyl coenzyme a suppress the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4α, J Biol Chem, 277, 15736, 10.1074/jbc.M200971200 · DOI
- Dorfman, 2006, Dietary fatty acids differentially modulate messenger RNA abundance of low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and microsomal triglyceride transfer protein in Golden-Syrian hamsters, Metabolism, 55, 635, 10.1016/j.metabol.2005.12.005 · DOI
- Pan, 2004, Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production, J Clin Invest, 113, 1277, 10.1172/JCI19197 · DOI · Paper page
- Caviglia, 2011, Different fatty acids inhibit apoB100 secretion by different pathways: unique roles for ER stress, ceramide, and autophagy, J Lipid Res, 52, 1636, 10.1194/jlr.M016931 · DOI
- López-Soldado, 2009, Suppression of VLDL secretion by cultured hepatocytes incubated with chylomicron remnants enriched in n-3 polyunsaturated fatty acids is regulated by hepatic nuclear factor-4alpha, Biochim Biophys Acta, 1791, 1181, 10.1016/j.bbalip.2009.08.004 · DOI
- Pettinelli, 2009, Enhancement in liver SREBP-1c/PPAR-alpha ratio and statuses in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion, Biochim Biophys Acta, 1792, 1080, 10.1016/j.bbadis.2009.08.015 · DOI · Paper page
- Marsman, 2011, Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model, J Gastroenterol Hepatol, 26, 356, 10.1111/j.1440-1746.2010.06326.x · DOI
- Man, 2006, Colocalization of SCD1 and DGAT2: implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis, J Lipid Res, 47, 1928, 10.1194/jlr.M600172-JLR200 · DOI · Paper page
- Assy, 2009, Olive oil consumption and non-alcoholic fatty liver disease, World J Gastroenterol, 15, 1809, 10.3748/wjg.15.1809 · DOI · Paper page
- Sato, 2007, Dietary palatinose and oleic acid ameliorate disorders of glucose and lipid metabolism in Zucker fatty rats, J Nutr, 137, 1908, 10.1093/jn/137.8.1908 · DOI
- Hussein, 2007, Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats, World J Gastroenterol, 13, 361, 10.3748/wjg.v13.i3.361 · DOI
- Buettner, 2006, Defining high-fat-diet rat models: metabolic and molecular effects of different fat types, J Mol Endocrinol, 36, 485, 10.1677/jme.1.01909 · DOI · Paper page
- Rector, 2008, Non-alcoholic fatty liver disease and the metabolic syndrome: an update, World J Gastroenterol, 14, 185, 10.3748/wjg.14.185 · DOI · Paper page
- Sookoian, 2008, Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review, J Hepatol, 49, 600, 10.1016/j.jhep.2008.06.012 · DOI · Paper page
- Cassagno, 2005, Low amounts of trans 18:1 fatty acids elevate plasma triacylglycerols but not cholesterol and alter the cellular defense to oxidative stress in mice, Br J Nutr, 94, 346, 10.1079/BJN20051512 · DOI
- Obara, 2010, Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice, J Hepatol, 53, 326, 10.1016/j.jhep.2010.02.029 · DOI
- Fernández-Quintela, 2007, The role of dietary fat in adipose tissue metabolism, Public Health Nutr, 10, 1126, 10.1017/S1368980007000602 · DOI
- Coenen, 2007, Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue, Diabetes, 56, 564, 10.2337/db06-1375 · DOI
- Boden, 2002, Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction, Eur J Clin Invest, 32, 14, 10.1046/j.1365-2362.32.s3.3.x · DOI · Paper page
- Schaffer, 2003, Lipotoxicity: when tissues overeat, Curr Opin Lipidol, 14, 281, 10.1097/00041433-200306000-00008 · DOI · Paper page
- Ibrahim, 2005, Ghafoorunissa. Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats, Metabolism, 54, 240, 10.1016/j.metabol.2004.08.019 · DOI
- Elmendorf, 2004, Fluidity of insulin action, Mol Biotechnol, 27, 127, 10.1385/MB:27:2:127 · DOI
- Nugent, 2001, Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma, J Biol Chem, 276, 9149, 10.1074/jbc.M009817200 · DOI
- Saravanan, 2005, Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue, Eur J Endocrinol, 153, 159, 10.1530/eje.1.01946 · DOI
- Manickam, 2010, Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes, Lipids Health Dis, 9, 57, 10.1186/1476-511X-9-57 · DOI
- Nicolas, 1991, Dietary (n-6) polyunsaturated fatty acids affect β-adrenergic receptor binding and adenylate cyclase activity in pig adipocyte plasma membrane, J Nutr, 121, 1179, 10.1093/jn/121.8.1179 · DOI
- Fickova, 1998, Dietary (n-3) and (n-6) polyunsaturated fatty acids rapidly modify fatty acid composition and insulin effects in rat adipocytes, J Nutr, 128, 512, 10.1093/jn/128.3.512 · DOI
- Mustad, 2006, Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse, Metabolism, 55, 1365, 10.1016/j.metabol.2006.06.007 · DOI
- Hartweg, 2009, Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes, Curr Opin Lipidol, 20, 30, 10.1097/MOL.0b013e328321b3be · DOI
- Djoussé, 2011, Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes, Am J Clin Nutr, 93, 143, 10.3945/ajcn.110.005603 · DOI · Paper page
- Long, 1996, Regulation of GLUT4 gene expression by arachidonic acid. Evidence for multiple pathways, one of which requires oxidation to prostaglandin E2, J Biol Chem, 271, 1138, 10.1074/jbc.271.2.1138 · DOI
- Tebbey, 1994, Arachidonic acid down-regulates the insulin-dependent glucose transporter gene (GLUT4) in 3T3-L1 adipocytes by inhibiting transcription and enhancing mRNA turnover, J Biol Chem, 269, 639, 10.1016/S0021-9258(17)42397-0 · DOI
- Sauma, 2006, PPAR-gamma response element activity in intact primary human adipocytes: effects of fatty acids, Nutrition, 22, 60, 10.1016/j.nut.2005.04.011 · DOI
- Tontonoz, 1994, mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer, Genes Dev, 8, 1224, 10.1101/gad.8.10.1224 · DOI · Paper page
- Oster, 2010, Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARγ mRNA, in 3T3-L1 adipocytes, Appl Physiol Nutr Metab, 35, 783, 10.1139/H10-076 · DOI
- Mozaffarian, 2004, Dietary intake of trans fatty acids and systemic inflammation in women, Am J Clin Nutr, 79, 606, 10.1093/ajcn/79.4.606 · DOI · Paper page
- Chambrier, 2002, Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma, Obes Res, 10, 518, 10.1038/oby.2002.70 · DOI
- Forman, 1995, 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma, Cell, 83, 803, 10.1016/0092-8674(95)90193-0 · DOI · Paper page
- Stewart, 1999, 11β-hydroxysteroid dehydrogenase, Vitam Horm, 57, 249, 10.1016/S0083-6729(08)60646-9 · DOI · Paper page
- Prasad, 2010, A novel genetically-obese rat model with elevated 11 beta-hydroxysteroid dehydrogenase type 1 activity in subcutaneous adipose tissue, Lipids Health Dis, 9, 132, 10.1186/1476-511X-9-132 · DOI
- Berger, 2001, Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity, J Biol Chem, 276, 12629, 10.1074/jbc.M003592200 · DOI · Paper page
- Mater, 1998, Arachidonic acid inhibits lipogenic gene expression in 3T3-L1 adipocytes through a prostanoid pathway, J Lipid Res, 39, 1327, 10.1016/S0022-2275(20)32513-X · DOI
- Brown, 2010, Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery, Curr Opin Lipidol, 21, 192, 10.1097/MOL.0b013e32833854ac · DOI
- Sessler, 1996, Regulation of stearoyl-CoA desaturase 1 mRNA stability by polyunsaturated fatty acids in 3T3-L1 adipocytes, J Biol Chem, 271, 29854, 10.1074/jbc.271.47.29854 · DOI
- Hotamisligil, 2005, Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes, Diabetes, 54, S73, 10.2337/diabetes.54.suppl_2.S73 · DOI · Paper page
- Nappo, 2002, Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals, J Am Coll Cardiol, 39, 1145, 10.1016/S0735-1097(02)01741-2 · DOI · Paper page
- Bradley, 2008, Dietary fatty acids differentially regulate production of TNF-α and IL-10 by murine 3T3-L1 adipocytes, Obesity, 16, 938, 10.1038/oby.2008.39 · DOI · Paper page
- Baer, 2004, Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized cross over study, Am J Clin Nutr, 79, 969, 10.1093/ajcn/79.6.969 · DOI · Paper page
- Suganami, 2007, Role of the toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages, Arterioscler Thromb Vasc Biol, 27, 84, 10.1161/01.ATV.0000251608.09329.9a · DOI · Paper page
- Youssef-Elabd, 2011, Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro, J Nutr Biochem
- Rasouli, 2008, Adipocytokines and the metabolic complications of obesity, J Clin Endocrinol Metab, 93, S64, 10.1210/jc.2008-1613 · DOI · Paper page
- Qatanani, 2009, Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice, J Clin Invest, 119, 531, 10.1172/JCI37273 · DOI · Paper page
- Granados, 2011, Distinct effects of oleic acid and its trans-isomer elaidic acid on the expression of myokines and adipokines in cell models, Br J Nutr, 105, 1226, 10.1017/S0007114510004885 · DOI
- Flachs, 2006, Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet, Diabetologia, 49, 394, 10.1007/s00125-005-0053-y · DOI · Paper page
- James, 2000, Dietary polyunsaturated fatty acids and inflammatory mediator production, Am J Clin Nutr, 71, 343S, 10.1093/ajcn/71.1.343S · DOI · Paper page
- Fleming, 2011, Cytochrome P450-dependent eicosanoid production and crosstalk, Curr Opin Lipidol, 22, 403, 10.1097/MOL.0b013e32834a9790 · DOI
- Spector, 2009, Arachidonic acid cytochrome P450 epoxygenase pathway, J Lipid Res, 50, S52, 10.1194/jlr.R800038-JLR200 · DOI · Paper page
- Mozaffarian, 2005, Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men, Circulation, 111, 157, 10.1161/01.CIR.0000152099.87287.83 · DOI · Paper page
Cited by
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
“concerning PUFA and inflammation is not consistent [89,90].”
BackgroundATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M., Saraiva, J., Chacra, A., Bianco, H., Afiune Neto, A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 633
Self-citationMcArdle, M. A., Finucane, O. M., Connaughton, R. M., McMorrow, A. M., & Roche, H. M. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00052 · Cited by 532
Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood
Drozdz, D., Alvarez-Pitti, J., Wójcik, M., Borghi, C., Gabbianelli, R., Mazur, A., Herceg-Čavrak, V., Lopez-Valcarcel, B. G., Brzeziński, M., Lurbe, E., et al. (2021) · Nutrients · doi:10.3390/nu13114176 · Cited by 409
Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00137 · Cited by 339
Metadata
- Authors
- Lottenberg, A. M., Afonso, M. D. S., Lavrador, M. S. F., Machado, R. M., & Nakandakare, E. R.
- Venue
- The Journal of Nutritional Biochemistry
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 23
- Issue
- 9
- Pages
- 1027-1040
- ISSN
- 0955-2863 (ISSN-L)
- OpenAlex
- W2163591544
- Cited by
- 220
- References
- 26
- FWCI
- 18.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of dietary fatty acids in the pathology of metabolic syndrome. https://app.cochat.ai/papers/10.1016/j.jnutbio.2012.03.004
- The paper
- Lottenberg, A. M., Afonso, M. D. S., Lavrador, M. S. F., Machado, R. M., & Nakandakare, E. R. (2012). The role of dietary fatty acids in the pathology of metabolic syndrome. The Journal of Nutritional Biochemistry. https://doi.org/10.1016/j.jnutbio.2012.03.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.